Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples